NEW YORK (360Dx) – With an anticipated buyers' market resulting from the Protecting Access to Medicare Act, Quest Laboratories went on a spending spree in 2017, announcing or completing 12 acquisitions during the year, or 21 percent of all M&A deals in the diagnostics space, making it the most acquisitive firm in the sector, according to an analysis by 360Dx.